The results showed that the protein levels of MMP-1, but not MMP-2, were drastically downregulated in a dose-dependent manner upon SNS-032 treatment in both the tested ESCC cells (Fig. 4D). The gene discussed is MMP1; the disease is esophageal squamous cell carcinoma.